fbpx

ThermoGenesis Receives Acknowledgement Letter from FDA Allowing Its SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit for Distribution

RANCHO CORDOVA, Calif., April 16, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that on Wednesday April 15th, following submission of notification to the U.S. Food and Drug Administration (FDA), the Company has received the necessary acknowledgement letter which … Continued

ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires Key Technologies to Develop Fully Human Polyclonal and Monoclonal Antibody Therapeutics for COVID-19

RANCHO CORDOVA, Calif., April 13, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that its joint venture, ImmuneCyte Life Sciences, Inc., has completed the acquisition of worldwide intellectual property for developing fully human antibody therapeutics for COVID-19. The acquired … Continued

ThermoGenesis and ImmuneCyte’s Rapid COVID-19 Testing Kit Featured on Local CBS News Titled: “Different Kind of Coronavirus Test”

RANCHO CORDOVA, Calif., April 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on a CBS 13 news segment titled, “Different Kind of Coronavirus Test”, regarding the Company’s SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit … Continued

ThermoGenesis’ Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: “Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes”

ThermoGenesis’ Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: “Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes”  RANCHO CORDOVA, Calif., April 2, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was … Continued

ThermoGenesis Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit

ThermoGenesis Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit RANCHO CORDOVA, Calif., March 31, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S. Food … Continued

ThermoGenesis Holdings Announces $3.5 Million Registered Direct Offering Priced At-the-Market

RANCHO CORDOVA, Calif., March 25, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase and sale of 1,000,002 shares of the company’s common … Continued

ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2019 and Provide a Corporate Strategic Update

Conference Call to be Held on March 24, 2020 RANCHO CORDOVA, Calif., March 18, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the year ended December 31, 2019 and … Continued

© 2020 ThermoGenesis Corp.
How may we help?